advertisement

Topcon

Survey of Ophthalmology 14

Showing records 1 to 14 | Display all abstracts in Survey of Ophthalmology

95250 Ocular manifestations in phakomatosis pigmentovascularis: Current concepts on pathogenesis, diagnosis, and management
Abdolrahimzadeh S
Survey of Ophthalmology 2021; 66: 482-492
95326 Sildenafil in ophthalmology: An update
Arora S
Survey of Ophthalmology 2022; 67: 463-487
95400 Pediatric uveitis: A comprehensive review
Maleki A; Anesi SD
Survey of Ophthalmology 2022; 67: 510-529
95250 Ocular manifestations in phakomatosis pigmentovascularis: Current concepts on pathogenesis, diagnosis, and management
Pugi DM
Survey of Ophthalmology 2021; 66: 482-492
95326 Sildenafil in ophthalmology: An update
Surakiatchanukul T
Survey of Ophthalmology 2022; 67: 463-487
95250 Ocular manifestations in phakomatosis pigmentovascularis: Current concepts on pathogenesis, diagnosis, and management
de Paula A
Survey of Ophthalmology 2021; 66: 482-492
95326 Sildenafil in ophthalmology: An update
Arora T
Survey of Ophthalmology 2022; 67: 463-487
95400 Pediatric uveitis: A comprehensive review
Look-Why S
Survey of Ophthalmology 2022; 67: 510-529
95326 Sildenafil in ophthalmology: An update
Cagini C
Survey of Ophthalmology 2022; 67: 463-487
95400 Pediatric uveitis: A comprehensive review
Manhapra A
Survey of Ophthalmology 2022; 67: 510-529
95250 Ocular manifestations in phakomatosis pigmentovascularis: Current concepts on pathogenesis, diagnosis, and management
Scuderi G
Survey of Ophthalmology 2021; 66: 482-492
95326 Sildenafil in ophthalmology: An update
Lupidi M
Survey of Ophthalmology 2022; 67: 463-487
95400 Pediatric uveitis: A comprehensive review
Foster CS
Survey of Ophthalmology 2022; 67: 510-529
95326 Sildenafil in ophthalmology: An update
Chhablani J
Survey of Ophthalmology 2022; 67: 463-487

Issue 22-2

Change Issue


advertisement

WGA Rescources